MAPK3 and prostate carcinoma: In prostate cancer patients, cancer cells secrete sEVs containing adrenomedullin which upregulates fatty acid oxidation via ERK1/2 and p38 MAPK axis contributing to the early weight loss associated with prostate cancer patients (Sagar et al., 2016).